(IN BRIEF) Causeway Therapeutics, a University of Glasgow spin-out, has announced strong Phase 2 results for its novel microRNA therapy, TenoMiR®, used to treat tennis elbow. The study, involving 123 patients across the UK and USA, showed significant improvements in … Read the full press release
Posted in Education, Healthcare, Industrial, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biotechnology, Causeway Therapeutics, Causeway Therapeutics Advances TenoMiR® Development Following Strong Phase 2 Results, clinical research, Declan Doogan, Derek Gilchrist, Glasgow City Council, Glasgow Riverside Innovation District, Iain McInnes, lateral epicondylitis, microRNA therapy, miR29a, Neal Millar, orthopaedic innovation, phase 2 trial, Phase 3 development, Promising Clinical Data Propel Glasgow Biotech Causeway Therapeutics Toward Full Development of TenoMiR®, Scott Rodeo, Scottish Enterprise, tendinopathy, tendon regeneration, tennis elbow, TenoMiR, University of Glasgow
(IN BRIEF) Fresenius Medical Care will present multiple studies at ASN Kidney Week 2025, highlighting how hemodiafiltration (HDF) enhances clinical outcomes and how artificial intelligence is transforming kidney care. One of the featured oral presentations links HDF to a reduced … Read the full press release
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Marketing, Pharma & Biotech, Science, Technology
Tagged AI Chatbot, AI in healthcare, ASN Kidney Week 2025, cardiovascular outcomes, clinical research, dialysis, digital innovation, Frank Maddux, Fresenius Medical Care, Fresenius Medical Care Highlights Real-World Benefits of Hemodiafiltration and AI Innovation at ASN Kidney Week in Houston, HDF, hemodiafiltration, HOUSTON, kidney disease, kidney therapy, nephrology, online high-volume HDF, patient care, precision medicine, Renal Research Institute
(IN BRIEF) Novartis announced a definitive agreement to acquire Avidity Biosciences for USD 12 billion in cash, in a move that strengthens its neuroscience franchise and accelerates its xRNA therapeutic strategy. The acquisition brings Avidity’s late-stage programs in myotonic dystrophy … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Switzerland
Tagged acquisition, Antibody Oligonucleotide Conjugates, AOCs, Avidity Biosciences, Basel, biopharma, biopharmaceutical innovation, biotechnology, clinical research, DM1, DMD, drug development, Duchenne muscular dystrophy, EXPLORE44 trial, facioscapulohumeral muscular dystrophy, FORTITUDE trial, FSHD, genetic medicine, HARBOR trial, muscle-directed therapy, myotonic dystrophy type 1, neuromuscular diseases, Novartis, Novartis Strengthens Neuroscience Franchise with Acquisition of Avidity Biosciences and Its Muscle-Directed RNA Platform, RNA delivery, RNA therapeutics, San Diego, SpinCo, Vas Narasimhan, xRNA strategy
(IN BRIEF) Sanofi’s investigational therapy efdoralprin alfa met all primary and key secondary endpoints in the Phase 2 ElevAATe study for alpha-1 antitrypsin deficiency emphysema, demonstrating superior efficacy compared to standard plasma-derived therapy. The results highlight its potential as the … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged AATD emphysema, alpha-1 antitrypsin deficiency, biotechnology, Christopher Corsico, clinical research, David Geffen School of Medicine, efdoralprin alfa, ElevAATe OLE, ElevAATe study, FDA Fast Track, functional AAT, Igor Barjaktarevic, orphan drug designation, phase 2 trial, protein replacement therapy, pulmonary medicine, rare disease, recombinant therapy, respiratory health, respiratory innovation, Sanofi, Sanofi’s Efdoralprin Alfa Shows Superior Results in Phase 2 AATD Emphysema Trial, SAR447537, UCLA
(IN BRIEF) In recognition of World Statistics Day 2025, The Institute of Cancer Research (ICR), London, is spotlighting the essential role of statisticians in advancing cancer research through reliable, transparent, and responsible data analysis. The event, themed “Quality statistics and … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged adaptive trial designs, artificial intelligence, biostatistics, cancer trials, clinical research, Clinical Trials and Statistics Unit, Covid-19 pandemic, CTSU, data transparency, Emily Alger, evidence-based decision making, ICR, ICR showcases how statistical science powers cancer research and clinical progress for World Statistics Day 2025, Machine Learning, oncology research, patient-reported outcomes, Professor Christina Yap, quality statistics, responsible research, statistical science, The Institute of Cancer Research celebrates the power of statistics in advancing cancer research ahead of World Statistics Day 2025, The Institute of Cancer Research London, University of Oxford, University of Warwick, World Statistics Day 2025
(IN BRIEF) The University of Twente, Medisch Spectrum Twente, and the Centre for Human Drug Research (CHDR) will open a new clinical research unit at MST on 10 October 2025. This expansion represents CHDR’s first facility outside Leiden and underscores … Read the full press release
Posted in Education, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged Centre for Human Drug Research, Centre for Human Drug Research opens new clinical unit at Medisch Spectrum Twente in partnership with University of Twente, CHDR, clinical research, clinical trials, drug development, Enschede, Healthcare Innovation, Leiden BioScience Park, Leiden University, Leiden University Medical Centre, medical technology, Medisch Spectrum Twente, MST, New clinical research unit at MST marks next step in partnership between University of Twente and Centre for Human Drug Research, TechMed Centre, therapeutic innovation, Twente, University of Twente, University of Twente and partners launch new Centre for Human Drug Research clinical research unit to advance therapeutic innovation in Twente, University of Twente joins CHDR and MST to position Twente as a hub for medical technology and therapeutic development, University of Twente joins forces with CHDR and Medisch Spectrum Twente to open new clinical research unit in Twente, UT
(IN BRIEF) Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduced relapse rates and prevented disability progression in patients with relapsing multiple sclerosis (RMS). The study revealed an annualized relapse … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Bruton’s tyrosine kinase, BTK inhibitor, clinical data, clinical research, clinical trial, data, disability, disability progression, fenebrutinib, FENopta, Levi Garraway, multiple sclerosis, Phase II, relapse rates, relapsing multiple sclerosis, RMS, Roche, treatment
(IN BRIEF) NHS Lanarkshire and the University of Glasgow have formalized a Strategic Partnership Agreement to transform healthcare delivery, advance clinical research, and improve health outcomes across Lanarkshire. This collaboration will focus on reducing health inequalities, enhancing patient care, and … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Investment, Management, Marketing, News, Technology, United Kingdom
Tagged clinical research, clinical trials, collaboration, health outcomes, healthcare delivery, Healthcare Innovation, Lanarkshire, NHS Lanarkshire, partnership, patient care, reducing health inequalities, staff development, strategic partnership, teaching and research, University of Glasgow
(IN BRIEF) Heart Failure 2025, organized by the Heart Failure Association (HFA) of the European Society of Cardiology, will take place in Belgrade, Serbia, from May 17 to 20, 2025. The congress will feature over 80 scientific sessions, including Late-Breaking … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Internet & Online, Investment, Management, Media, News, Science, Serbia, Technology
Tagged Belgrade, cardiology, clinical research, European Society of Cardiology, global healthcare events, healthcare professionals, Heart Failure 2025, Heart Failure Association, heart failure treatment, HFA Young, Immersive learning, late-breaking science, medical education, scientific congress
(IN BRIEF) ZEISS has launched the Axioscan 7 spatial biology, a high-performance slide scanner designed for clinical research applications in spatial biology. The system supports high-throughput, automated imaging for multiplex immunofluorescence (mIF) assays, providing researchers with faster, more efficient, and … Read the full press release
Posted in Business, Electronics & Machinery, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged AI-powered image analysis, automated scanning, Axioscan 7, biomarker discovery, clinical research, Dr. Michael Albiez, drug development, fluorescence imaging, high-performance slide scanner, high-throughput, LIMS, microscopy, MIF, multiplex immunofluorescence, research automation, spatial biology, translational research, Ultivue, ZEISS
(IN BRIEF) The University of Liverpool is leading two critical projects focused on decarbonising healthcare. The Greener Trials project, led by Professor Paula Williamson, aims to reduce the carbon footprint of clinical trials through an open science approach, collaborating with … Read the full press release
Posted in Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged carbon footprint, carbon hotspots, clinical research, clinical trials, decarbonisation, Emissions Reduction, Greener Trials, healthcare sustainability, National Institute for Health and Care Research, net zero, NHS, NHS carbon footprint, One Health Systems, Open Science, pharmaceutical industry, Professor Paula Williamson, Professor Tim Jones, South African Medical Research Council, sustainability in healthcare, Sustainable Healthcare Coalition, UK healthcare, UK Research and Innovation, University of Exeter, University of Liverpool, Wellcome
(IN BRIEF) The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel in London. This event offers a platform for pharma R&D and patient advocacy to discuss … Read the full press release
Posted in France, Healthcare, Marketing, Pharma & Biotech, Science, Switzerland, United Kingdom
Tagged Alfred Samuels, AstraZeneca, Azafaros, Beyza Klein, Biotech, Biotechnology Conference, Boehringer Ingelheim, Bre Bugbee-Barrett, Catherine Coulouvrat MD, Chiesi Farmaceutici SpA, clinical development, clinical operations, clinical research, clinical research enterprise, clinical trial, clinical trials, Conference Forum, decentralized clinical trials, Gisela Linthorst, GSK, Harry Verbunt, HTA/Regulatory requirements, Johnson & Johnson Innovative Medicine, Lea-Isabelle Proulx PhD, life post-cancer diagnosis, Marisa Minetti, Medicine Development, Patient Advocacy, patient engagement, patient engagement in drug development, patient experience, Patient Recruitment, Patient Retention, Patients as Partners, Patients as Partners Europe, Peter DiBiaso, pharma, Pharmaceutical Conference, Regeneron, research and development, Roche, Royal National Hotel, Sanofi, Temi Olonisakin MD, The Conference Forum, Valerie Bowling
(IN BRIEF) HealthSage AI has launched its open platform featuring three clinical applications aimed at streamlining physician workflows. These applications, powered by an optimized Large Language Model, improve administrative tasks, billing accuracy, and data exchange. In collaboration with Amsterdam UMC … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Technology
Tagged administrative burden, AI healthcare applications, AI platform, AI-Driven Solutions, Amsterdam UMC Heart Center, clinical data transformer, clinical research, data-driven healthcare, FHIR, generative AI, healthcare AI, Healthcare Innovation, healthcare workflow, HealthSage AI, ICD-10, Large Language Model, medical coding, medical data standards, open platform, partnership, patient care, SNOMED-CT, value-based healthcare, visit preparation
(IN BRIEF) The University of Liverpool and Liverpool University Hospitals NHS Foundation Trust (LUHFT) launched the Dr Ronald Finn Fellowships on June 24, 2024. The initiative honors the late Dr. Ronald Finn and introduces five fellows who will undertake significant … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Science, Technology, United Kingdom
Tagged Andrew Davison, clinical research, Dr Ronald Finn Fellowships, Dr. Ronald Finn, Hassan Burhan, leadership, Liverpool University Hospitals NHS Foundation Trust (LUHFT), Ned Gilbert-Kawai, partnership, Professor Terry Jones, Professor Tom Walley, Rishi Mukherjee, Sir Cyril Clarke, University of Liverpool, Yamini Krishna
(IN BRIEF) The Conference Forum announced the launch of the 8th annual Patients as Partners® Europe meeting, scheduled for May 14-15, 2024, at Plaisterers’ Hall in London, England. This event brings together pharma R&D and patient advocacy to discuss patient … Read the full press release
Posted in Healthcare, Marketing, Pharma & Biotech, United Kingdom
Tagged 8th annual Patients as Partners® Europe, AbbVie, Anders Lassen, Andrew Garvey, Annie Gilbert, Astellas, AstraZeneca, Biotech, Boehringer Ingelheim, clinical operations, clinical research, clinical trials, Conference, David James, decentralized clinical trials, Derek Stewart, diversifying clinical trials, diversity, drug development, England, GSK, Health Equity, inclusivity, inclusivity in clinical research, Ipsen, LGBTQ+ oncology, Lisa Kerr, London, Lundbeck, Novartis, Novo Nordisk, Oleksandr Gorbenko, Parexel, Patient Advocacy, patient engagment, patient experience mapping, Patrick Gallogly, Pfizer, pharma, Plaisterers’ Hall, Prostate Cancer Research, Rosamund Round, Sanofi, Sarah Zenner Dolan, Stephen Head, The Conference Forum, Valerie Bowling, Victoria DiBiaso, , Alfred Samuel
(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will take place in London on June 12-13, 2023. The event will focus on achieving greater representation in clinical research, building … Read the full press release
Posted in Government, Healthcare, News, Non Profit, Pharma & Biotech, United Kingdom
Tagged 7th annual European Patients as Partners®, biotechnology, Boehringer Ingelheim, Center for BME Health, clinical development, clinical research, Clinical Research conference, clinical trials, Community Engagement, CSL Behring, Deirdre BeVard, Diversity in Clinical Research, drug development, government, Health Equity, Healthcare, Hospital, Lundbeck, Medicine Development, Medicine Lifestyle, Medicines Development, Novartis, Patient Advocacy, Patient Centricity, Patient Communities, patient engagement, Patient Perspective, Patient Recruitment, Patient Retention, Patient Voice, Patients as Partners, Pharmaceutical, research and development, Sanofi, The Conference Forum, Thistle Hotel Marble Arch, Valerie Bowling
(PRESS RELEASE) GENEVA, 29-Apr-2022 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the company won five awards at the 2022 CRO Leadership Awards underlining its industry-leading work. The categories the company won award in … Read the full press release
Posted in Awards, Business, Industrial, Management, News, Science, Switzerland, Technology
Tagged analytical testing, Antwerp University Hospital, Awards, Clinical Pharmacology Unit, clinical research, commercialization, cro, CRO Leadership Awards, CRO Quality Benchmarking, CROs, Ed Miseta, Health Science, Industry Standard Research, Johan Pype, life sciences, Manufacturing, SGS, survey
(COMMUNIQUÉ DE PRESSE) GENEVA, 29-Apr-2022 — /EuropaWire/ — SGS, le leader mondial des tests, de l’inspection et de la certification, a annoncé que la société a remporté cinq prix aux CRO Leadership Awards 2022, soulignant son travail de pointe dans … Read the full press release
Posted in Awards, Business, Industrial, Management, News, Science, Switzerland
Tagged analytical testing, Antwerp University Hospital, Awards, Clinical Pharmacology Unit, clinical research, commercialization, cro, CRO Leadership Awards, CRO Quality Benchmarking, CROs, Ed Miseta, Health Science, Industry Standard Research, Johan Pype, life sciences, Manufacturing, SGS
(PRESS RELEASE) New York, NY, United States, 5-Jan-2022 — /EuropaWire/ — The Conference Forum announced the launch of the 6th annual EU Patients as Partners in Medicines Development conference to take place virtually on January 24-25th, 2022 GMT time. This … Read the full press release
Posted in Education, Healthcare, Internet & Online, News, Pharma & Biotech, Science, Technology
Tagged 6th annual EU Patients as Partners, AbbVie, Biotech, clinical development, clinical research, clinical trial, clinical trials, Conference, Conference Forum, data, dct, decentralized, DNA, EMD Serono, Gilead Sciences, GSK, INNOVATION, Ipsen, Janssen, Johnson & Johnson, Medicines Development, Merck KGaA, Michaela Dinboeck, MS trial, Noema Pharma, Novartis, Parkinsons disease, patient engagement, patient input, Patient Voice, patients, Patients as Partners Europe, Pfizer, pharma, Pharmaceutical, Pierre Fabre, Regeneron, Takeda, UCB
A leading North East charity is contributing £1m to fund new roles at Newcastle University fighting childhood cancer. NEWCASTLE, 05-Sep-2016 — /EuropaWire/ — Just eight years after the launch of the Sir Bobby Robson Foundation, thanks to unwavering support, the … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?